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Abstract
Purpose
To investigate the influence of daily oral iron supplementation on changes in hemoglobin
mass (Hbmass) and iron parameters after 2–4 weeks of moderate altitude exposure.
Methods
Hematological data collected from 178 athletes (98 males, 80 females) exposed to moder-
ate altitude (1,350–3,000 m) were analysed using linear regression to determine how alti-
tude exposure combined with oral iron supplementation influenced Hbmass, total iron
incorporation (TII) and blood iron parameters [ferritin and transferrin saturation (TSAT)].
Results
Altitude exposure (mean ± s: 21 ± 3 days) increased Hbmass by 1.1% [-0.4, 2.6], 3.3% [1.7,
4.8], and 4.0% [2.0, 6.1] from pre-altitude levels in athletes who ingested nil, 105 mg and
210 mg respectively, of oral iron supplement daily. Serum ferritin levels decreased by
-33.2% [-46.9, -15.9] and 13.8% [-32.2, 9.7] from pre-altitude levels in athletes who supple-
mented with nil and 105 mg of oral iron supplement daily, but increased by 36.8% [1.3, 84.8]
in athletes supplemented with 210 mg of oral iron daily. Finally, athletes who ingested either
105 mg or 210 mg of oral iron supplement daily had a greater TII compared with non-supple-
mented athletes (0 versus 105 mg: effect size (d) = -1.88 [-2.56, -1.17]; 0 versus 210 mg:
effect size (d) = -2.87 [-3.88, -1.66]).
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Conclusion
Oral iron supplementation during 2–4 weeks of moderate altitude exposure may enhance
Hbmass production and assist the maintenance of iron balance in some athletes with low
pre-altitude iron stores.
Introduction
Prolonged moderate altitude exposure (i.e. several weeks at>2,000 m) enhances oxygen trans-
port and utilization by stimulating hematological [i.e. increased hemoglobin mass (Hbmass)]
and non-hematological (i.e. increased skeletal muscle buffer capacity, mitochondrial density,
glycolytic and oxidative enzyme concentration) adaptations [1]. Substantial inter- and intra-
individual variability exists in the magnitude of the Hbmass response to prolonged moderate
altitude exposure [2], owing to several factors including the hypoxic dose [3], variations in kid-
ney erythropoietin production during early adaptation [4], as well as injury and illness [5].
Sufficient iron stores are required to support an hypoxic-mediated increase in heme synthe-
sis and iron-dependent enzyme production during prolonged altitude exposure. Indeed, alti-
tude exposure is associated with a three- to five-fold increase in erythropoiesis, with erythroid
iron uptake approaching 100% of its maximal capacity during the first few days of adaptation
[6]. However, low pre-altitude iron stores, or an inability to rapidly mobilise iron from reticulo-
endothelial macrophages may reduce the amount of iron available to support hematological
and non-hematological adaptations during initial altitude exposure. For example, red cell vol-
ume did not improve following four weeks of moderate altitude (2,500 m) exposure in nine
non-iron supplemented, iron deficient runners (pre-altitude serum ferritin: 15 ± 3 μgL-1), sug-
gesting athletes require sufficient pre-altitude serum ferritin levels to support accelerated eryth-
ropoiesis at altitude [7]. In contrast, Ryan et al. [8] reported that 7 of 9 non-iron supplemented
female subjects exposed to 5,000 m for 16 days increased their Hbmass despite low pre-altitude
serum ferritin levels (28.9 ± 15.5 μgL-1). Moreover, these authors reported a weak correlation
(r = 0.33, p = 0.16) between pre-altitude serum ferritin levels and the percentage change in
Hbmass after 16 days of high altitude exposure. Therefore, the influence of pre-altitude ferritin
levels on the Hbmass response to prolonged altitude exposure is currently unclear.
To date, there are no clear iron supplementation guidelines for athletes planning to under-
take moderate altitude exposure. Currently, it is thought that raising an athlete’s pre-altitude
iron stores via oral iron supplementation in the weeks before altitude exposure may assist them
to maintain a healthy iron balance when training at altitude [9]. Furthermore, although oral
iron supplementation guidelines at sea level recommend providing oral iron supplements to
athletes with serum ferritin levels<35 μgL-1 [10], athletes with otherwise healthy serum ferri-
tin levels (i.e.>35 μgL-1) planning to undertake a period of altitude exposure, may also need
to ingest oral iron supplements to provide sufficient iron for erythropoiesis and iron-depen-
dent enzyme production. Furthermore, there is some evidence that iron supplementation may
alleviate the symptoms of altitude-related illnesses such as acute mountain sickness [11], and
help to maintain cognitive function in hypoxia [12].
Relatively few studies have investigated the influence of oral iron supplementation on
Hbmass production in elite athletes undertaking moderate altitude exposure. In one study, oral
iron supplementation (200 mg elemental iron daily) did not enhance the Hbmass response rela-
tive to a placebo in 17 National level boxers exposed to moderate altitude (1,800 m) for 18 days
[13]. Oral iron supplementation may have been unnecessary in this group since their pre-
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altitude serum ferritin levels were clinically normal (serum ferritin: 70 ± 23 μgL-1) and the
overall hypoxic dose was lower than that typically used during Live High: Train Low (LHTL)
protocols (i.e. 21 days exposure to 3,000 m). However, male and female endurance athletes
with serum ferritin levels<40 μgL-1, or who are training for long periods at moderate (2,000–
3000 m) or high altitudes (>3,000 m) may require oral iron supplementation to sustain accel-
erated erythropoiesis [9].
To this end, we modelled the Hbmass and blood iron parameters [serum ferritin, and trans-
ferrin saturation (TSAT)] response to prolonged moderate altitude exposure in a large sample
of well-trained athletes. Additionally, we investigated how different oral iron supplement doses
moderated the Hbmass and iron parameter responses in well-trained athletes.
Methods
Ethics Statement
The Human Ethics Committee at the Australian Institute of Sport granted ethical approval for
each altitude exposure. Before each altitude exposure, the risks and benefits associated with
participation were explained to each participant in full before written informed consent was
obtained. Additionally, the Human Research Ethics Committee at Edith Cowan University
granted ethical approval for data analysis.
Participants
De-identified hematological data (iron parameters and Hbmass) from 178 athletes (males = 98,
females = 80) who undertook altitude exposure at the Australian Institute of Sport (AIS) from
2006 to 2014 were extracted from the AIS medical records database. This sample represents the
entire population of endurance athletes who undertook altitude exposure at the AIS during this
time. Athletes were from one of seven sports, including; cycling (n = 60), rowing (n = 9), swim-
ming (n = 2), triathlon (n = 5), distance running (n = 43), race walking (n = 39) and water polo
(n = 20). Athletes were AIS scholarship holders and/or national team members who undertook
altitude exposure as part of a training camp, or who attended the AIS for research purposes.
Hence, some aspects of the combined data set presented here have been published previously
[14–19].
Three females were diagnosed by a sports physician as having hereditary hemochromatosis
and were removed at the data extraction phase and not included in the final data analysis. Ath-
letes’ iron status was classified based on their pre-altitude exposure serum ferritin levels. Iron
deficiency was categorised into three stages: Stage 1 (iron deficiency): serum ferritin<35 μgL-1,
TSAT>16%; Stage 2 (iron deficient erythropoiesis): serum ferritin<20 μgL-1, TSAT>16%;
Stage 3: serum ferritin<12 μgL-1, TSAT<16% is normally associated with anemia [20].
Prior to altitude exposure, 21 athletes (5 males, serum ferritin: 30.1 ± 5.3 μgL-1; 16 females,
serum ferritin: 29.7 ± 3.4 μgL-1) met the criteria for Stage 1 iron deficiency. Six athletes met
the criteria for Stage 2 iron deficiency (2 males, serum ferritin: 17.4 ± 0.7 μgL-1; 4 females,
serum ferritin: 15.2 ± 3.7 μgL-1) and one female athlete met the criteria for Stage 3 iron defi-
ciency (serum ferritin: 11.8 μgL-1).
Altitude Training
Four altitude training camps employed a classic [Live High: Train High, (LHTH)] training
approach and were conducted at either Stelvio Pass, Italy (~2,700 m, n = 5; [15]), St. Moritz,
Switzerland (~1,850 m, n = 5), Perisher Valley, Australia (~1,720 m, n = 8) or Thredbo, Austra-
lia (~1,350 m, n = 13). The remaining altitude camps used a Live High: Train Low (LHTL)
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approach (n = 147) and were conducted in normobaric, altitude-training facility at the AIS
[16], designed to simulate 3,000 m altitude. During LHTL camps, athletes were required to
spend a minimum of 14 hours per day at altitude, whilst they trained near sea level (~600 m,
Canberra, Australia). One LHTL group lived at 3,000 m but performed three training sessions
per week at 2,200 m [19].
Iron Supplementation
Iron supplements (Ferro Grad C, 325 mg ferrous sulphate & 1,000 mg ascorbic acid, delivering
105 mg elemental iron, Abbott Laboratories, Botany Bay, Australia) were administered to ath-
letes one week prior to, and for the duration of, altitude exposure. The iron supplement dose
administered during altitude exposure was based on athletes’ pre-altitude ferritin levels. Fifteen
athletes (13 males, 2 females) were not iron supplemented because of high (i.e.>100 μgL-1)
pre-altitude serum ferritin levels [serum ferritin (mean ± s): 164 ± 35 μgL-1]. Additionally, 144
athletes (82 males, 62 females) ingested one iron tablet per day (105 mg elemental iron; serum
ferritin: 76 ± 32 μgL-1). Finally, 19 athletes (3 males, 16 females) ingested two iron tablets per
day (210 mg elemental iron; serum ferritin: 25 ± 7 μgL-1).
Hemoglobin Mass (Hbmass)
Hemoglobin mass was measured before and after altitude exposure via the optimised 2 min
carbon monoxide (CO) rebreathing technique [21]. Briefly, this technique involved the
rebreathing of a bolus of ~1.2 mLkg-1 CO for 2 min. Capillary blood samples were taken before
and 7 min after rebreathing CO, and measured five times using an OSM3 Hemoximeter (Radi-
ometer, Copenhagen, Denmark) to determine the percentage change in carboxyhemoglobin
(HbCO). Hemoglobin mass was then calculated from the change in %HbCO before and after
CO rebreathing. The typical error of measurement for Hbmass in our laboratory is ~1.8%, 90%
CI [1.3, 2.2] [22].
Iron Parameters
Blood samples were collected at rest from a forearm antecubital vein by a trained phlebotomist.
Pre- and post-altitude iron parameters (serum ferritin and TSAT) were measured at the AIS
using either a Hitachi 911 (Boehringer, GmbH, Mannaheim, Ingelheim, Germany) or a
COBAS Integra 400 (Roche Diagnostics, Switzerland) via immunoturbidimetry [23], with the
same analyser always used for each pre versus post comparison.
Total Iron Incorporation
Total Iron Incorporation (TII) was calculated to determine total erythrocyte iron uptake (HII)
and iron stored as ferritin during altitude exposure (SII) [24]. Here, TII = [(ΔHbmass (g) × 3.38
mg) + (Δ Ferritin (μgL-1) × 8 mg)], where, 3.38 mg represents the typical iron content of Hb
[25] and 8 mg represents the iron content of ferritin [26].
Statistics
Linear Regression. The influence of altitude exposure on Hbmass and iron parameters was
modelled using a multiple regression in the R statistics programme [27]. Hbmass, serum ferritin,
TSAT and were log-transformed before analysis, back transformed, and then expressed as a
percentage difference from the specified reference level to improve interpretability. Data were
first modelled to investigate the influence of the following covariates on the change in Hbmass
in response to prolonged moderate altitude exposure: sex (2 levels: male, female), altitude
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category (2 levels: natural, simulated), altitude duration (<2 weeks, 2–3 weeks,>3 weeks), alti-
tude elevation (3 levels: 1,350–1,850 m, 2.600–2,800 m, 3,000 m) and sport (7 levels: race walk-
ing, distance running, road cycling, triathlon, rowing, swimming and waterpolo). There were
no significant differences between the changes in Hbmass or iron parameters following altitude
exposure for sex and altitude category, thus these data were pooled during the final analysis.
Furthermore, since the interaction between sport and oral iron supplement dose yielded a
small sample size (n = 1 to 2), we chose to omit these covariates from the final model.
The percentage change in Hbmass and serum iron parameters during altitude exposure was
analysed via linear regression with daily oral iron supplement dose (3 levels: none, 105 mg, 210
mg) as the only model covariate. Results are reported as the percentage change from pre-alti-
tude values, with 95% confidence intervals to denote the imprecision of the point-estimate.
Effect Sizes. The magnitudes of the change in pre-altitude versus post-altitude values for
TII, HII and SII are expressed as a Cohen’s d effect size [28]. Effect sizes were interpreted using
Cohen’s Scale for Effect Sizes [28] with the following qualitative descriptors: trivial (0.0–0.2),
small (0.2–0.6),moderate (0.6–1.2), large (1.2–2.0), very large (2.0–4.0). Additionally, the impre-
cision of the estimate was quantified using 95% confidence intervals. Since TII and SII included
negative values, non-normality was addressed by adding 1,000 to these values before applying
a Box-Cox (power) transformation [29].
Results
Twenty-one athletes were classified as Stage 1 iron deficient (16 males, 5 females; serum ferri-
tin: 29.8 ± 3.8 μgL-1, TSAT: 26.7 ± 12.9%) and six athletes were classified as Stage 2 iron defi-
cient (4 females, 2 males; serum ferritin: 15.9 ± 3.1 μgL-1, TSAT: 27.2 ± 11.8%). We also
classified athletes as hematological responders or non-responders based on a change in Hbmass
greater than the typical error of measurement for the CO rebreathing technique (i.e. 1.8%)
[22]. Based on this criterion, 120 athletes (57 males, 63 females) athletes were classified as
hematological responders and 58 athletes (35 males, 23 females) as non-responders.
Hbmass and Iron Parameter Response
The Hbmass and iron parameter responses to moderate altitude exposure adjusted for oral iron
supplement doses are presented in Table 1. Hbmass increased from pre-altitude levels in athletes
who ingested 105 mg and 210 mg of oral iron supplements (both p< 0.01). In comparison,
Hbmass did not increase significantly from pre-altitude levels following moderate altitude expo-
sure in non-iron supplemented athletes (p = 0.14). ΔHbmass was 2.1% [0.3, 4.0] and 2.9% [0.5,
5.3] higher in athletes who ingested 105 mg and 210 mg of oral iron per day compared with
non-iron supplemented athletes. Serum ferritin decreased following moderate altitude expo-
sure in non-iron supplemented athletes and those athletes who ingested 105 mg (both
p< 0.01), but increased relative to pre-altitude levels in those athletes who ingested 210 mg of
Table 1. Parameter estimates (Est.) with 95% confidence intervals (CI) for the changes (Δ) in Hbmass, ferritin and transferrin saturation (TSAT) dur-
ing prolongedmoderate altitude exposure, when controlled for oral iron supplement dose.
Effect Δ Hbmass(%) Δ Ferritin (%) Δ TSAT (%)
Supplement Dose Est. 95% CI n Est. 95% CI n Est. 95% CI n
None 1.1 [-0.4, 2.6] 15 -33.2 [-46.9, -15.9] 10 -22.3 [-48.7, 17.8] 4
105 mg 3.3 [1.7, 4.8] 144 -13.8 [-32.2, 9.7] 97 -6.8 [-6.8, 42.6] 75
210 mg 4.0 [2.0, 6.1] 19 36.8 [1.3, 84.8] 15 10.9 [-31.6, 80.0] 11
doi:10.1371/journal.pone.0135120.t001
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oral iron per day (p< 0.01). Finally, oral iron supplementation did not influence the ΔTSAT
following moderate altitude exposure (p> 0.05).
Total Iron Incorporation
Fig 1 compares the TII after altitude exposure in iron supplemented and non-iron supple-
mented athletes. Overall, TII was higher in athletes who were supplemented with either 105
mg or 210 mg of iron orally per day during altitude exposure compared with non-iron supple-
mented athletes. Specifically, iron supplementation of either 105 mg or 210 mg of oral iron per
day during altitude exposure induced a large and very large increase in TII (0 versus 105 mg:
d = 1.52 [0.95, 2.07]; 0 versus 210 mg: d = 2.13 [1.24, 2.92]).
Discussion
This study found that prolonged, moderate altitude exposure (median elevation: 3,000 m;
median duration: 21 days) enhanced erythroid iron incorporation and Hbmass in iron supple-
mented athletes. Moreover, daily oral iron supplementation attenuated the reduction in serum
ferritin levels following altitude exposure, compared with non-iron supplemented athletes.
Therefore, we conclude that daily oral iron supplementation may support Hbmass production
and maintain iron balance in athletes with low pre-altitude serum ferritin levels during moder-
ate altitude exposure.
Hbmass Response to Moderate Altitude
In the current study, moderate altitude exposure enhanced Hbmass by ~3–4% in oral iron sup-
plemented athletes. These findings support Gore et al. [30], who calculated that an individual
athlete exposed to moderate altitude>2,200 m for 300 h might expect a mean increase in
Hbmass of ~3.2%. In contrast, non-iron supplemented athletes in the current study did not
enhance their Hbmass beyond the typical error of measurement of the CO rebreathing technique
Fig 1. Iron incorporation into the iron storage (SII) and red cell compartment (HII) for each category of
iron supplement dose [0 mg (n = 15), 105 mg (n = 144), 210 mg (n = 19)].Overall, total iron incorporation
(TII) was higher in iron-supplemented athletes compared with non-iron supplemented athletes.
doi:10.1371/journal.pone.0135120.g001
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(~1.8%) [30]. We speculate that oral iron supplementation may have supported further Hbmass
production in these non-iron supplemented athletes. However, it is also possible that poor intes-
tinal iron absorption and/or erythroid iron uptake also limited iron incorporation by erythroid
precursor cells, thereby compromising Hbmass production in these athletes. Therefore, although
our findings largely suggest that oral iron supplementation supports Hbmass production in ath-
letes undertaking moderate altitude exposure, further research is required to establish a clear
serum ferritin threshold to guide oral iron supplementation in athletes.
Our findings that moderate altitude exposure enhances Hbmass by 3–4% in iron-supple-
mented athletes contrast those of the Monte Carlo simulation by Rasmussen, Siebenmann,
Diaz & Lundby [31]. These authors concluded altitude exposure must exceed two weeks at an
altitude of>4,000 m to increase red cell volume. However, Garvican-Lewis, Halliday, Abbiss,
Saunders & Gore [32] recently demonstrated a 3.1% increase in Hbmass in distance runners fol-
lowing three weeks exposure to 1,800 m. We speculate that differences in oral iron supplemen-
tation practices could explain some of the discrepancies between our findings and those of
Rasmussen, Siebenmann, Diaz & Lundby [31]. Specifically, whereas 72% of the athletes ana-
lysed by Rasmussen, Siebenmann, Diaz & Lundby [31] were not iron supplemented, 92% of
athletes in our study ingested oral iron supplements. Therefore, routine oral iron supplementa-
tion may ensure athletes are able to support erythropoiesis when exposed to moderate altitude
exposure for two weeks or more.
Total Iron Incorporation & Iron Parameter Responses
We estimated the amount of the iron mobilised from the iron storage compartment and
directed to the erythron based on the change in Hbmass and serum ferritin levels following
moderate altitude exposure. In general, oral iron supplemented athletes incorporated more
iron into the erythron and mobilised less iron from the iron storage compartment compared
with non-iron supplemented athletes. Therefore, oral iron supplementation may assist athletes
to maintain a healthy iron balance at altitude, in turn ensuring sufficient iron is available to
support accelerated erythropoiesis at altitude.
Athletes supplemented with 210 mg of oral iron per day increased their serum ferritin levels
following moderate altitude exposure, despite a large Hbmass response. Such an observation
indicates the oral iron supplement dose exceeded bone marrow iron uptake in these athletes
resulting in the storage of excess iron. One explanation for this observation is that the iron
absorption mechanisms were already up-regulated before altitude exposure owing to these ath-
letes presenting as Stage 1 iron deficient. Iron deficiency and altitude exposure both result in
systemic hypoxia and stimulate similar changes in iron metabolism. Two such changes in iron
metabolism are an increase in HIF-2α transcription [33,34] and hepcidin suppression [35–37].
Hepcidin suppression is a favourable response to hypoxia that improves iron export from stor-
age cells by reducing the degradation of ferroportin iron export channels located on the cellular
surface of iron storage cells. Simultaneously, HIF-2α increases the expression of ferroportin
[34] and proteins involved in iron absorption (i.e. divalent-metal transporter-1, duodenal cyto-
chrome B) [38]. Finally, the hypoxic stabilisation of HIF-1α enhances the expression of iron
transport proteins (i.e. TfR-1) [39]. These changes in iron absorption and transport mecha-
nisms in iron deficient athletes during altitude exposure may explain why oral iron supplemen-
tation effectively replenished the iron storage compartment in athletes who ingested 210 mg of
oral iron supplements per day.
In contrast to iron-supplemented athletes, non-iron supplemented athletes mobilised a
large amount of iron from storage sites during altitude exposure, but incorporated less iron
into the erythron. Such a response may indicate impaired iron delivery to the erythron, since
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these athletes had otherwise healthy serum ferritin levels before altitude exposure. Although
not measured in the current study, an exercise-induced increase in hepcidin during exercise
recovery in non-supplemented athletes may have temporarily inhibited iron export from retic-
uloendothelial macrophages, thus limiting its delivery to the erythron during the post-exercise
recovery period. In support of this hypothesis, Peeling et al. [40] showed that athletes with high
pre-exercise serum ferritin levels (>100 μgL-1) at sea level exhibit a significantly greater post-
exercise hepcidin response 3 h following interval exercise than athletes with low serum ferritin
levels (serum ferritin<30 μgL-1). A similar response may also occur during LHTL, despite
hepcidin suppression at altitude [35], thus temporarily decreasing iron delivery to the bone
marrow during the exercise recovery. However, the post-exercise hepcidin response during
LHTL is yet to be investigated.
Serum Ferritin Threshold for Iron-Supplementation at Moderate Altitude
To date, no clear serum ferritin threshold exists to guide oral iron supplementation for athletes
planning an altitude sojourn. At sea level, athletes with serum ferritin levels<35 μgL-1 are
often prescribed oral iron supplements to restore and maintain iron balance [10]. A higher
serum ferritin threshold is likely required for athletes undertaking altitude exposure to com-
pensate for an hypoxic-mediated increase in erythroid iron uptake at altitude. In the absence of
clear criteria, we supplemented both males and females with serum ferritin levels<100 μgL-1.
We based our rationale on the findings of Brugnara, Chambers, Malynn, Goldberg & Kruskall
[41], who showed healthy subjects with serum ferritin levels<100 μgL-1 developed a func-
tional iron deficiency when undergoing synthetic EPO administration. We acknowledge that
synthetic EPO administration bypasses an hypoxic-mediated increase in HIF-1α and HIF-2α
transcription during prolonged altitude exposure. Therefore, some athletes may have sufficient
iron stores to support erythropoiesis during moderate altitude exposure despite serum ferritin
levels<100 μgL-1, since HIF activation stimulates the expression of proteins involved in intes-
tinal iron absorption and iron export from reticuloendothelial macrophages. Based on our
results, we are unable to define a specific serum ferritin threshold at which to commence oral
iron supplementation in athletes undertaking prolonged altitude exposure. Thus, further
research is required to establish altitude-specific serum ferritin thresholds to guide oral iron
supplementation during moderate altitude exposure.
Some disadvantages of oral iron supplementation include side effects such as nausea, flatu-
lence and gastrointestinal discomfort. Furthermore, oral iron supplements transiently increases
oxidative stress on the gut mucosa and may disrupt the gut microbacteria [42]. Hence, if oral
iron supplements are not well-tolerated, then parenteral iron supplementation may be indi-
cated to increase an athlete’s iron stores in preparation for altitude exposure [9]. However, par-
enteral iron supplementation should be considered in consultation with a trained sports
physician. In light of our findings, the development of altitude-specific, iron supplementation
guidelines could help to optimise athletes’ hematological adaptations to prolonged altitude
exposure. Furthermore, refinement of iron supplement guidelines for athletes undertaking alti-
tude exposure may also help to avoid the health risks associated with unnecessary oral iron
supplementation in athletes with otherwise healthy iron stores.
Limitations
This study has several limitations. Firstly, we were unable to analyse athletes’ training volume
or dietary iron intake as covariates in our statistical model. We recommend future studies
account for these factors to determine their influence on the Hbmass and iron parameter
response to altitude exposure. Secondly, exercise and/or illness may have increased
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inflammatory cytokines at altitude, in turn increasing serum ferritin levels owing as part of the
acute phase response [43]. In the current study, venous blood samples were collected before
exercise under standardised conditions. Therefore, we believe it is unlikely that an exercise-
related increase in inflammatory cytokines influenced the blood iron parameter levels reported
here. However, we cannot exclude the possibility than an IL-6 mediated increase in hepcidin
during post-exercise recovery may have compromise intestinal iron absorption and/or iron
recycling from reticuloendothelial macrophages. Thirdly, the low sample size of the non-iron
supplemented and 210 mg oral iron supplement group meant we were unable to extend our
model to consider whether sport discipline and altitude duration moderated the Hbmass
response to altitude exposure. Thus, these factors may also have influenced the Hbmass response
to moderate altitude exposure reported here. However, the influence of altitude duration on
the Hbmass response to moderate altitude has previously been analysed by Gore et al. [30].
Finally, given that prolonged altitude exposure enhances several iron-dependent oxidative
enzymes, such as cytochrome C oxidase and citrate synthase, it is likely that some of the iron
derived from oral iron supplements was directed to the mitochondria to support the synthesis
of these iron dependent non-haem proteins.
Conclusion
Two to four weeks of low-moderate altitude exposure (1,350–3,000 m) increased Hbmass in
well-trained iron supplemented athletes. Daily oral iron supplementation improved erythroid
iron incorporation and resulted in higher serum ferritin levels in athletes who ingested 105 mg
and 210 mg of oral iron supplements per day, relative to non-supplemented athletes. We con-
clude that oral iron supplementation likely supports Hbmass production during moderate alti-
tude exposure, and may help to replenish the iron storage compartment in some iron deficient
athletes.
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